Drugs / LE051
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06900049 | Oct 2024 → Sep 2026 overdue | Duchenne muscular dystrophy | Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LE051 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06900049 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “delivered via adeno-associated virus” NCT06900049 ↗ |
| Route | Intravenous | “single intravenous infusion” NCT06900049 ↗ |